Prenylation: From bacteria to eukaryotes

Molecular Biology

Volumn 47, Issue 5, 2013, Pages 622-633

  Marakasova, E S ^a,b   Akhmatova, N K ^b   Amaya, M ^a   Eisenhaber, B ^c,d,e   Eisenhaber, F ^c   van Hoek, M L ^a   Baranova, A V ^a,f  

^a GEORGE MASON UNIVERSITY   (United States)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c BIOINFORMATICS INSTITUTE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

Author keywords

AnkB proteins; Francisella; mechanism; prenylation; prenylation inhibitors; PrePS; SifA

Indexed keywords

EID: 84885597339     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893313050130     Document Type: Review

References (71)

1. Liang P. H., Ko T. P., Wang A. H. 2002. Structure, mechanism and function of prenyltransferases. Eur. J. Biochem. 269, 3339-3354.
2. Casey P. J. 1992. Biochemistry of protein prenylation. J. Lipid Res. 33, 1731-1740.
3. Al-Quadan T., Price C. T., London N., Schueler-Furman O., AbuKwaik Y. 2011. Anchoring of bacterial effectors to host membranes through host-mediated lipidation by prenylation: A common paradigm. Trends Microbiol. 19, 573-579.
4. Kamiya Y., Sakurai A., Tamura S., Takahashi N. 1978. Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem. Biophys. Res. Commun. 83, 1077-1083.
5. Anderegg R. J., Betz R., Carr S. A., Crabb J. W., Duntze W. 1988. Structure of Saccharomyces cerevisiae mating hormone a-factor: Identification of S-farnesyl cysteine as a structural component. J. Biol. Chem. 263, 18236-18240.
6. Gelb M. H., Scholten J. D., Sebolt-Leopold J. S. 1998. Protein prenylation: From discovery to prospects for cancer treatment. Curr. Opin. Chem. Biol. 2, 40-48.
7. Zhang F. L., Casey P. J. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65, 241-269.
8. Chan L. N., Hart C., Guo L., et al. 2009. A novel approach to tag and identify geranylgeranylated proteins. Electrophoresis. 30, 3598-3606.
9. Wollack J. W., Zeliadt N. A., Mullen D. G., et al. 2009. Multifunctional prenylated peptides for live cell analysis. J. Am. Chem. Soc. 131, 7293-7303.
10. Gao J., Liao J., Yang G. Y. 2009. CAAX-box protein, prenylation process and carcinogenesis. Am. J. Transl. Res. 1, 312-325.
11. Roberts P. J., Mitin N., Keller P. J., et al. 2008. Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J. Biol. Chem. 283, 5150-5163.
12. Kellogg B. A., Poulter C. D. 1997. Chain elongation in the isoprenoid biosynthetic pathway. Curr. Opin. Chem. Biol. 1, 570-578.
13. Ogura K., Koyama T. 1998. Enzymatic aspects of isoprenoid chain elongation. Chem. Rev. 98, 1263-1276.
14. Wolfe L. M., Mahaffey S. B., Kruh N. A., Dobos K. M. 2010. Proteomic definition of the cell wall of Mycobacterium tuberculosis. J. Proteome Res. 9, 5816-5826.
15. Fujihashi M., Zhang Y. W., Higuchi Y., Li X. Y., et al. 2001. Crystal structure of cis-prenyl chain elongating enzyme, undecaprenyl diphosphate synthase. Proc. Natl. Acad. Sci. U. S. A. 98, 4337-4342.
16. Ko T. P., Chen Y. K., Robinson H., et al. 2001. Mechanism of product chain length determination and the role of a flexible loop in Escherichia coli undecaprenyl-pyrophosphate synthase catalysis. J. Biol. Chem. 276, 47474-47482.
17. Reid T. S., Terry K. L., Casey P. J., Beese L. S. 2004. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J. Mol. Biol. 343, 417-433.
18. Benetka W., Koranda M., Maurer-Stroh S., Pittner F., Eisenhaber F. 2006. Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo. BMC Biochem. 7, 6.
19. Roskoski R., Jr. 2003. Protein prenylation: A pivotal posttranslational process. Biochem. Biophys. Res. Commun. 303, 1-7.
20. Eisenhaber B., Eisenhaber F. 2010. Prediction of post-translational modification of proteins from their amino acid sequence. Methods Mol. Biol. 609, 365-384.
21. Maurer-Stroh S., Eisenhaber F. 2005. Refinement and prediction of protein prenylation motifs. Genome Biol. 6, R55.
22. Maurer-Stroh S., Koranda M., Benetka W., et al. 2007. Towards complete sets of farnesylated and geranylgeranylated proteins. PLoS Comp. Biol. 3, e66.
23. Krzysiak A. J., Rawat D. S., Scott S. A., Pais J. E., Handley M., et al. 2007 Combinatorial modulation of protein prenylation. ACS Chem. Biol. 2, 385-389.
24. Trueblood C. E., Ohya Y., Rine J. 1993. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4260-4275.
25. Navarro-Lerida I., Sanchez-Perales S., Calvo M., et al. 2012. A palmitoylation switch mechanism regulates Rac1 function and membrane organization. EMBO J. 31, 534-551.
26. Novelli G., D'Apice M. R. 2012. Protein farnesylation and disease. J. Inher. Metab. Dis. 35, 917-926.
27. Al-Khodor S., Abu Kwaik Y. 2010. Triggering Ras signalling by intracellular Francisella tularensis through recruitment of PKCalpha and betaI to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosol. Cell. Microbiol. 12, 1604-1621.
28. Eastman R. T., Buckner F. S., Yokoyama K., Gelb M. H., van Voorhis W. C. 2006. Thematic review series: Lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J. Lipid Res. 47, 233-240.
29. De Smedt F., Boom A., Pesesse X., Schiffmann S. N., Erneux C. 1996. Post-translational modification of human brain type I inositol-1, 4, 5-trisphosphate 5-phosphatase by farnesylation. J. Biol. 271, 10419-10424.
30. Chakrabarti D., Da Silva T., Barger J., et al. 2002. Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. J. Biol. Chem. 277, 42066-42073.
31. Yokoyama K., Lin Y., Stuart K. D., Gelb M. H. 1997. Prenylation of proteins in Trypanosoma brucei. Mol. Biochem. Parasitol. 87, 61-69.
32. Yokoyama K., Trobridge P., Buckner F. S., et al. 1998. Protein farnesyltransferase from Trypanosoma brucei: A heterodimer of 61- and 65-kDa subunits as a new target for antiparasite therapeutics. J. Biol. Chem. 273, 26497-26505.
33. Buckner F. S., Yokoyama K., Nguyen L., et al. 2000. Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei. J. Biol. Chem. 275, 21870-21876.
34. Engelson E. J., Buckner F. S., van Voorhis W. C. 2011. An essential farnesylated kinesin in Trypanosoma brucei. PloS ONE. 6, e26508.
35. Sorek N., Gutman O., Bar E., et al. 2011. Differential effects of prenylation and s-acylation on type I and II ROPS membrane interaction and function. Plant Physiol. 155, 706-720.
36. Sohn H. Y., Son K. H., Kwon C. S., Kwon G. S., Kang S. S. 2004. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait, and Echinosophora koreensis Nakai. Phytomed.: Int. J. Phytother. Phytopharmacol. 11, 666-672.
37. Mayaka R. K., Langat M. K., Omolo J. O., Cheplogoi P. K. 2012. Antimicrobial prenylated acetophenones from berries of Harrisonia abyssinica. Planta Med. 78, 383-386.
38. Price C. T., Jones S. C., Amundson K. E., Kwaik Y. A. 2010. Host-mediated post-translational prenylation of novel dot/icm-translocated effectors of Legionella pneumophila. Front. Microbiol. 1, 131.
39. Reinicke A. T., Hutchinson J. L., Magee A. I., et al. 2005. A Salmonella typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery. J. Biol. Chem. 280, 4620-4627.
40. Brumell J. H., Goosney D. L., Finlay B. B. 2002. SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic. 3, 407-415.
41. Price C., Al-Quadan T., Santic M., Jones S. C., Abu Kwaik Y. 2010. Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila. J. Exp. Med. 207, 1713-1726.
42. Al-Quadan T., Kwaik Y. A. 2011. Molecular characterization of exploitation of the polyubiquitination and farnesylation machineries of Dictyostelium discoideum by the AnkB F-box effector of Legionella pneumophila. Front. Microbiol. 2, 23.
43. Al-Khodor S., Price C. T., Habyarimana F., Kalia A., Abu Kwaik Y. 2008. A Dot/Icm-translocated ankyrin protein of Legionella pneumophila is required for intracellular proliferation within human macrophages and protozoa. Mol. Microbiol. 70, 908-923.
44. Ivanov S. S., Charron G., Hang H. C., Roy C. R. 2010. Lipidation by the host prenyltransferase machinery facilitates membrane localization of Legionella pneumophila effector proteins. J. Biol. Chem. 285, 34686-34698.
45. Al-Quadan T., Price C. T., Abu Kwaik Y. 2012. Exploitation of evolutionarily conserved amoeba and mammalian processes by Legionella. Trends Microbiol. 20, 299-306.
46. Richards A. M., Von Dwingelo J. E., Price C. T., Abu Kwaik Y. 2013. Cellular microbiology and molecular ecology of Legionella-amoeba interaction. Virulence. 4(4), 307-314.
47. Asare R., Abu Kwaik Y. 2010. Molecular complexity orchestrates modulation of phagosome biogenesis and escape to the cytosol of macrophages by Francisella tularensis. Environ. Microbiol. 12, 2559-2586.
48. Fujikura K., Maki Y., Ohya N., Satoh M., Koyama T. 2008. Kinetic studies of Micrococcus luteus B-P 26 undecaprenyl diphosphate synthase reaction using 3-desmethyl allylic substrate analogs. Biosci. Bbiotechnol. Biochem. 72, 851-855.
49. Lytle C. A., Gan Y. D., Salone K., White D. C. 2001. Sensitive characterization of microbial ubiquinones from biofilms by electrospray/mass spectrometry. Environ. Microbiol. 3, 265-272.
50. Bonitz T., Alva V., Saleh O., Lupas A. N., Heide L. 2011. Evolutionary relationships of microbial aromatic prenyltransferases. PloS ONE. 6, e27336.
51. Metzger U., Keller S., Stevenson C. E., Heide L., Lawson D. M. 2010. Structure and mechanism of the magnesium-independent aromatic prenyltransferase CloQ from the clorobiocin biosynthetic pathway. J. Mol. Biol. 404, 611-626.
52. Sugiyama A., Linley P. J., Sasaki K., Kumano T., Yamamoto H., et al. 2011. Metabolic engineering for the production of prenylated polyphenols in transgenic legume plants using bacterial and plant prenyltransferases. Metab. Eng. 13, 629-637.
53. Kumano T., Richard S. B., Noel J. P., Nishiyama M., Kuzuyama T. 2008. Chemoenzymatic syntheses of prenylated aromatic small molecules using Streptomyces prenyltransferases with relaxed substrate specificities. Bioorg. Med. Chem. 16, 8117-8126.
54. Ozaki T., Mishima S., Nishiyama M., Kuzuyama T. 2009. NovQ is a prenyltransferase capable of catalyzing the addition of a dimethylallyl group to both phenyl-propanoids and flavonoids. J. Antibiot. (Tokyo). 62, 385-392.
55. Ozaki T., Nishiyama M., Kuzuyama T. 2013. Novel tryptophan metabolism by a potential gene cluster that is widely distributed among Actinomycetes. J. Biol. Chem. 288, 9946-9956.
56. Horn M. P., Knecht S. M., Rushing F. L., et al. 2008. Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates. J. Pharmacol. Exp. Ther. 326, 135-143.
57. Vanhaesebroeck B., Waterfield M. D. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253, 239-254.
58. Tsuji F., Ishihara A., Kurata K., et al. 2012. Geranyl modification on the tryptophan residue of ComXRO-E-2 pheromone by a cell-free system. FEBS Lett. 586, 174-179.
59. Tsuji F., Ishihara A., Nakagawa A., et al. 2012. Lack of the consensus sequence necessary for tryptophan prenylation in the ComX pheromone precursor. Biosci. Biotechnol. Biochem. 76, 1492-1496.
60. Dumelin C. E., Chen Y., Leconte A. M., Chen Y. G., Liu D. R. 2012. Discovery and biological characterization of geranylated RNA in bacteria. Nature Chem. Biol. 8, 913-919.
61. Benetka W., Koranda M., Eisenhaber F. 2006. Protein prenylation: An (almost) comprehensive overview on discovery history, enzymology, and significance in physiology and disease. Monatsh. Chem. 137, 1241-1281.
62. Liang P. H. 2009. Reaction kinetics, catalytic mechanisms, conformational changes, and inhibitor design for prenyltransferases. Biochemistry. 48, 6562-6570.
63. Appels N. M., Beijnen J. H., Schellens J. H. 2005. Development of farnesyl transferase inhibitors: A review. Oncologist. 10, 565-578.
64. Britten C. D., Rowinsky E. K., Soignet S., et al. 2001. A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778, 123 in patients with solid malignancies. Clin. Cancer Res. Am. Assoc. Cancer Res. 7, 3894-3903.
65. Reid T. S., Long S. B., Beese L. S. 2004. Crystallographic analysis reveals that anticancer clinical candidate L-778, 123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes. Biochemistry. 43, 9000-9008.
66. Gelb M. H., Brunsveld L., Hrycyna C. A., et al. 2006. Therapeutic intervention based on protein prenylation and associated modifications. Nature Chem. Biol. 2, 518-528.
67. Hast M. A., Fletcher S., Cummings C. G., et al. 2009. Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase. Chem. Biol. 16, 181-192.
68. Howe R., Kelly M., Jimah J., Hodge D., Odom A. R. 2013. Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum. Eukaryotic Cell. 12, 215-223.
69. Winter-Vann A. M., Kamen B. A., Bergo M. O., et al. 2003. Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate. Proc. Natl. Acad. Sci. U. S. A. 100, 6529-6534.
70. Thurnher M., Nussbaumer O., Gruenbacher G. 2012. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin. Cancer Res. Am. Assoc. Cancer Res. 18, 3524-3531.
71. Rice K. R., Koch M. O., Cheng L., Masterson T. A. 2012. Dyslipidemia, statins, and prostate cancer. Exp. Rev. Anticancer Ther. 12, 981-990.